MINIMALLY INVASIVE SURFACTANT TREATMENT VERSUS STANDARD THERAPY IN PRETERM INFANTS AT BIRTH (OPTIMIST-A TRIAL): AN ANALYSIS OF INITIAL HOSPITALISATIONCOSTS AND RESOURCE CONSUMPTION

被引：0
|
作者：
Cox, I [1 ]
de Graaff, B. [1 ]
Otahal, P. [1 ]
Kamlin, O. [2 ]
Orsini, F. [3 ]
De Paoli, A. [4 ]
Clark, H. [5 ]
Soll, R. [6 ]
Carlin, J. [7 ]
Davis, P. [7 ]
Dargaville, P. [4 ]
Palmer, A. J. [1 ]
机构：
[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[2] Royal Womens Hosp, Melbourne, Vic, Australia
[3] Murdoch Childrens Res Inst, Parkville, Vic, Australia
[4] Royal Hobart Hosp, Hobart, Tas, Australia
[5] Princess Anne Hosp, Southampton, Hants, England
[6] Univ Vermont, Burlington, VT USA
[7] Univ Melbourne, Melbourne, Vic, Australia
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE56
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 16 条
  • [1] The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation
    Peter A Dargaville
    Camille Omar F Kamlin
    Antonio G De Paoli
    John B Carlin
    Francesca Orsini
    Roger F Soll
    Peter G Davis
    BMC Pediatrics, 14
  • [2] The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation
    Dargaville, Peter A.
    Kamlin, Camille Omar F.
    De Paoli, Antonio G.
    Carlin, John B.
    Orsini, Francesca
    Soll, Roger F.
    Davis, Peter G.
    BMC PEDIATRICS, 2014, 14
  • [3] Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome The OPTIMIST-A Randomized Clinical Trial
    Dargaville, Peter A.
    Kamlin, C. Omar F.
    Orsini, Francesca
    Wang, Xiaofang
    De Paoli, Antonio G.
    Kutman, H. Gozde Kanmaz
    Cetinkaya, Merih
    Kornhauser-Cerar, Lilijana
    Derrick, Matthew
    Ozkan, Hilal
    Hulzebos, Christian, V
    Schmolzer, Georg M.
    Aiyappan, Ajit
    Lemyre, Brigitte
    Kuo, Sheree
    Rajadurai, Victor S.
    O'Shea, Joyce
    Biniwale, Manoj
    Ramanathan, Rangasamy
    Kushnir, Alla
    Bader, David
    Thomas, Mark R.
    Chakraborty, Mallinath
    Buksh, Mariam J.
    Bhatia, Risha
    Sullivan, Carol L.
    Shinwell, Eric S.
    Dyson, Amanda
    Barker, David P.
    Kugelman, Amir
    Donovan, Tim J.
    Tauscher, Markus K.
    Murthy, Vadivelam
    Ali, Sanoj K. M.
    Yossuck, Pete
    Clark, Howard W.
    Soll, Roger F.
    Carlin, John B.
    Davis, Peter G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (24): : 2478 - 2487
  • [4] Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants Follow-Up of the OPTIMIST-A Randomized Clinical Trial
    Dargaville, Peter A.
    Kamlin, C. Omar F.
    Orsini, Francesca
    Wang, Xiaofang
    De Paoli, Antonio G.
    Kanmaz Kutman, H. Gozde
    Cetinkaya, Merih
    Kornhauser-Cerar, Lilijana
    Derrick, Matthew
    Ozkan, Hilal
    Hulzebos, Christian V.
    Schmoelzer, Georg M.
    Aiyappan, Ajit
    Lemyre, Brigitte
    Kuo, Sheree
    Rajadurai, Victor S.
    O'Shea, Joyce
    Biniwale, Manoj
    Ramanathan, Rangasamy
    Kushnir, Alla
    Bader, David
    Thomas, Mark R.
    Chakraborty, Mallinath
    Buksh, Mariam J.
    Bhatia, Risha
    Sullivan, Carol L.
    Shinwell, Eric S.
    Dyson, Amanda
    Barker, David P.
    Kugelman, Amir
    Donovan, Tim J.
    Goss, Kevin C. W.
    Tauscher, Markus K.
    Murthy, Vadivelam
    Ali, Sanoj K. M.
    Clark, Howard W.
    Soll, Roger F.
    Johnson, Samantha
    Cheong, Jeanie L. Y.
    Carlin, John B.
    Davis, Peter G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (11): : 1054 - 1063
  • [5] OPTIMIST-A Trial Investigators. Minimally invasive surfactant therapy vs sham treatment and death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome-reply. (vol 327, pg 1614, 2022)
    Dargaville, P. A.
    Carlin, J. B.
    Davis, P. G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (11): : 2151 - 2151
  • [6] Efficacy of minimally invasive surfactant therapy in moderate and late preterm infants: A multicentre randomized control trial
    Olivier, Francois
    Nadeau, Sophie
    Belanger, Sylvie
    Julien, Anne-Sophie
    Masse, Edith
    Ali, Nabeel
    Caouette, Georges
    Piedboeuf, Bruno
    PAEDIATRICS & CHILD HEALTH, 2017, 22 (03) : 120 - 124
  • [7] Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome
    Wang, Xing-An
    Chen, Lih-Ju
    Chen, Shan-Ming
    Su, Pen-Hua
    Chen, Jia-Yuh
    PEDIATRICS AND NEONATOLOGY, 2020, 61 (02): : 210 - 215
  • [8] Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
    Sabzehei, Mohammad Kazem
    Basiri, Behnaz
    Shokouhi, Maryam
    Ghahremani, Sajad
    Moradi, Ali
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2022, 65 (04) : 188 - 193
  • [9] Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome Reply
    Dargaville, Peter A.
    Carlin, John B.
    Davis, Peter G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1614 - 1615
  • [10] Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial
    Oncel, Mehmet Yekta
    Arayici, Sema
    Uras, Nurdan
    Alyamac-Dizdar, Evrim
    Sari, Fatma Nur
    Karahan, Sevilay
    Canpolat, Fuat Emre
    Oguz, Serife Suna
    Dilmen, Ugur
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2016, 101 (04): : F323 - F328
12